Literature DB >> 3209794

Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol.

G Eisenhofer1, D S Goldstein, T G Ropchak, H Q Nguyen, H R Keiser, I J Kopin.   

Abstract

To elucidate the source and physiological significance of plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) as metabolites of noradrenaline (NA), unlabeled and tritium-labeled NA [( 3H]NA) were infused into conscious rats and the formation of labeled and unlabeled DHPG and MHPG examined. Animals were pretreated with clorgyline to determine the effects of inhibiting monoamine oxidase type A (MAO-A), with desipramine to determine the effects of blockade of NA neuronal uptake, or with reserpine to determine the effects of interference with vesicular translocation of NA. Inhibition of neuronal uptake prevented the formation of DHPG from exogenous NA and halved the formation of MHPG, indicating that DHPG is derived from NA metabolized intraneuronally and that MHPG is derived from NA metabolized extraneuronally and from DHPG produced intraneuronally. Blockade of vesicular translocation of NA with reserpine increased DHPG formation from exogenous NA by 300% and MHPG formation by 70%, consistent with enhanced availability of NA in the neuronal cytoplasm for metabolism by MAO-A. About 74% of NA recaptured by sympathetic nerves was estimated to be sequestered into storage vesicles. Endogenous DHPG and MHPG were derived mainly (60-70%) from leakage of NA from storage vesicles and to a smaller extent (30-40%) from NA recaptured after exocytotic release. An increased plasma DHPG to NA ratio with no change in the MHPG to NA ratio during infusions of physiologically active NA demonstrated that changes in plasma MHPG do not necessarily follow changes in DHPG. Consideration of the intra- and extraneuronal sources of plasma DHPG and MHPG, their main derivation from NA directly released into the neuronal cytoplasm and the influences of neuronal uptake and translocation of NA into storage vesicles is essential for the correct interpretation of plasma concentrations of these metabolites in the evaluation of sympathetic nervous function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3209794     DOI: 10.1016/0165-1838(88)90130-0

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  20 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

Authors:  E Schömig; C L Schönfeld; T Halbrügge; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 3.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

4.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

5.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

6.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

7.  Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats.

Authors:  G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

8.  Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.

Authors:  J P Finberg; K Pacak; I J Kopin; D S Goldstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

9.  Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.

Authors:  David A Mitchell; Gavin Lambert; Niels H Secher; Peter B Raven; Johannes van Lieshout; Murray D Esler
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

10.  Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.

Authors:  G Eisenhofer; H S Cox; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.